Altasciences Chosen by Virpax to Support the Development of a New Drug to Prevent Spread of Flu-like
LAVAL, Québec--(BUSINESS WIRE)--#Altasciences--Altasciences is pleased to have been chosen by Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX) (“Virpax”), a company specializing in developing non-addictive products for pain management, PTSD, central nervous system (CNS) disorders, and viral barrier indications, to conduct...
Robert Cavosi Julie Ann Cabana Steve Mason Kyle Klepner Department Of Defense National Institutes Of Health
Source: pharmiweb.com